Zenas BioPharma Inc. (ZBIO)
NASDAQ: ZBIO
· Real-Time Price · USD
16.82
0.06 (0.36%)
At close: Aug 15, 2025, 3:59 PM
17.00
1.07%
After-hours: Aug 15, 2025, 05:40 PM EDT
Zenas BioPharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Revenue | n/a | 10M | 5M | n/a | n/a | n/a | n/a | 50M | n/a | n/a | n/a |
Cost of Revenue | 12K | 23K | 33K | 36K | 35K | 33K | 20.42M | 26K | n/a | n/a | n/a |
Gross Profit | -12K | 10M | 5M | -36K | -35K | -33K | -20.42M | 50M | n/a | n/a | n/a |
Operating Income | -55.16M | -37.33M | -55.62M | -40.98M | -39.7M | -27.58M | -24.78M | 35.62M | -28.91M | -19.09M | -18.99M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -52.2M | -33.78M | -52.17M | -38.61M | -37.98M | -27.8M | -24.29M | 35.61M | -29.05M | -19.1M | -18.99M |
Net Income | -52.18M | -33.57M | -52.6M | -38.61M | -37.98M | -27.8M | -24.59M | 35.61M | -29.05M | -19.1M | -18.99M |
Selling & General & Admin | 12.14M | 12.41M | 11.47M | 7.45M | 5.89M | 4.93M | 4.36M | 5.02M | 3.99M | 3.74M | 3.22M |
Research & Development | 43.03M | 34.91M | 49.16M | 33.53M | 33.81M | 22.64M | 20.42M | 9.35M | 14.91M | 15.35M | 15.77M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10M | n/a | n/a |
Operating Expenses | 55.16M | 47.33M | 60.62M | 40.98M | 39.7M | 27.58M | 24.78M | 14.38M | 28.91M | 19.09M | 18.99M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 55.16M | 47.33M | 60.62M | 40.98M | 39.7M | 27.58M | 24.78M | 14.38M | 28.91M | 19.09M | 18.99M |
Income Tax Expense | 20K | -205K | 429K | n/a | n/a | n/a | 301K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 41.87M | 41.8M | 41.79M | 41.78M | 38.32M | 38.32M | 38.32M | 41.78M | 38.32M | 38.32M | 38.32M |
Shares Outstanding (Diluted) | 41.87M | 41.8M | 41.79M | 41.78M | 38.32M | 38.32M | 38.32M | 41.78M | 38.32M | 38.32M | 38.32M |
EPS (Basic) | -1.25 | -0.8 | -1.26 | -0.92 | -0.99 | -0.73 | -0.64 | 0.21 | -0.76 | -0.5 | -0.5 |
EPS (Diluted) | -1.25 | -0.8 | -1.26 | -0.92 | -0.99 | -0.73 | -0.64 | 0.21 | -0.76 | -0.5 | -0.5 |
EBITDA | -55.16M | -33.76M | -55.59M | -40.95M | -39.67M | -27.55M | -24.75M | 35.65M | -18.88M | -19.06M | -18.96M |
EBIT | -52.2M | -33.78M | -55.62M | -40.98M | -39.7M | -27.58M | -24.78M | 35.62M | -18.91M | -19.09M | -18.99M |
Depreciation & Amortization | 12K | 23K | 33K | 36K | 35K | 33K | 30K | 26K | 29K | 28K | 25K |